Added to YB: 2020-02-21
Pitch date: 2020-02-21
AMYT LN [bullish]
Amryt Pharma plc
+11.28%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases.
Market Cap
$940.7M
Pitch Price
$1.28
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-1.2K
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Amryt Pharma PLC AMYT LN
A summary for this pitch has not been created yet.
Read full article (0 min)